Decaderm, Decadron, Decaspray, Dextenza, Dexycu, Hemady, Hexadrol, Maxidex, Ozurdex (dexamethasone) is a small molecule pharmaceutical. Dexamethasone was first approved as Decaderm on 1982-01-01. It is used to treat addison disease, allergic rhinitis perennial, ankylosing spondylitis, brain edema, and bursitis amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. It is known to target glucocorticoid receptor and mineralocorticoid receptor. Maxitrol's patents are valid until 2037-12-18 (FDA).
|Indication||addison disease, allergic rhinitis perennial, ankylosing spondylitis, brain edema, bursitis, collagen diseases, dermatitis herpetiformis, hypercalcemia, iritis, keratitis, leukemia, macular edema, multiple myeloma, mycosis fungoides, nausea, pemphigus, pulmonary tuberculosis, rheumatic diseases, sarcoidosis, septic shock, systemic lupus erythematosus, thrombocytopenic purpura idiopathic, thyroiditis, ulcerative colitis, uveitis, vomiting|